KYMR Stock Price - Kymera Therapeutics, Inc. logo

KYMR Stock Price

Kymera Therapeutics, Inc.

$124.35
-$3.22(-2.53%)
57
Overall
50
Value
66
Tech
55
Quality
How is this score calculated?
Market Cap
$10.62B
Volume
492.92K
52W Range
$62.91 - $142.92
Target Price
$143.88

KYMR stock price is $124.35 (-2.53% on the day), giving Kymera Therapeutics, Inc. a market cap of $10.62B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

KYMR Stock Overview

Price
$124.34
Previous close
$127.57
Open
$127.44
Market cap
$10.62B
52-week range
$62.91 - $142.92
1-year price target
$143.88
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
57

About Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc., together with its subsidiary, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, which are in Phase I and IND-enabling respectively. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

ABCD
1SymbolPriceChangeVol
2KYMR$124.35-2.5%492.92K
3
4
5
6

Get Kymera Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.